Skip to main content

Table 3 Type of treatment and prevalence parasitological diagnosis before treatment by source among individuals who reported having fever in last two weeks and who took action (N = 2,035).

From: Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan

  Use of any drug, % (95% CI) (n/N = 1,935/2,035) Use of anti-malarials, % (95% CI) (n/N = 875/2,025) Use of other drugs, % (95% CI) (n/N = 1,060/2,035) Parasitologically tested for malaria before any treatment, % (95% CI) (n = 1,015/2,035)*
Overall 95.4 (94.4-96.4) 42.6 (39.2-46.0) 57.4 (54.0-60.8) 52.8 (48.6-57.0)
By treatment source
Government     
Hospital 29.0 (25.1-32.9) 28.2 (23.1-33.4) 29.6 (25.4-33.7) 38.8 (33.1-44.6)
Health centre 30.3 (26.4-34.3) 33.7 (28.2-39.2) 27.7 (23.7-31.7) 36.9 (31.4-42.4)
Basic health unit 11.4 (8.1-14.5) 11.4 (7.4-15.5) 11.3 (8.1-14.6) 4.6 (2.8-6.2)
Community Health Worker 6.9 (4.5-9.3) 5.9 (3.2-8.6) 7.7 (4.9-10.6) 3.4 (1.9-5.0)
Private     
Health facility/pharmacy/drug Store 15.3 (12.8-17.7) 16.0 (12.3-19.7) 14.7 (12.0-17.5) 15.2 (11.6-18.9)
Shop 5.5 (4.0-6.9) 3.8 (2.2-5.3) 6.8 (4.8-8.8) 0.4 (0.0-0.9)
Other 1.6 (0.9-2.3) 9.5 (0.2-1.7) 2.2 (1.0-3.3) 0.5 (0.0-1.1)
  1. Proportions are weighted and cluster adjusted.
  2. *Individuals tested for malaria when reporting at a health facility with fever. 57% of these received anti-malarials compared to 29% of those who were not tested. It was not possible to discern whether only the positive cases were treated with anti-malarials because of problems with recall and incompleteness of test status.